Shamon, Lisa A., et al., “Evaluation of the Mutagenic, Cytotoxic, and Antitumor Potential of Triptolide, a highly Oxygenated Diterpene Isolated from Tripterygium Wilfordii,” Cancer Letters (1997) vol. 112:113-117.* |
Wiley, Steven R., et al., “Identification and Characterization of a New Member for the TNF Family that Induces Apoptosis,” Immunity (1995) vol. 3:673-682.* |
Walczak, Hening et al., “Tumoricidal Activity of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand In Vivo,” Immunity (Feb. 1999) vol. 5(2): 157-163.* |
Lee, K.Y et al., “PG490(Triptolide) Cooperates with Tumor Necrosis Factor to Induce Apoptosis in Tumor Cells,” Biological Chemistry, vol.274, No. 19, 1999 pp. 13451-13455.* |
Lee et al, (May 7, 1999), “PG490 (Triptolide) Cooperates with Tumor Necrosis Factor-α to Induce Apoptosis in Tumor Cells,” Journal of Biological Chemistry, vol. 274(19):13451-13455. |
Keane et al. (Feb. 1, 1999), “Chemotherapy Augments TRAIL-Induced Apoptosis in Breast Cell Lines,” Cancer Research, vol. 59:734-741. |
Snell et al. (1997), “Activity of TNF-Related Apoptosis-Inducing Ligand (TRAIL) in Haematological Malignancies,” British Journal of Hematology, vol. 99:618-624. |
Tengchaisri et al. (1998), “Antitumor Activity of Triptolide Against Cholangiocarcinoma Growth in vitro and in Hamsters,” Cancer Letters, vol. 133:169-175. |
Baker, Stacey J., et al., “Modulation of Life and Death by the TNF Receptor Superfamily,” Oncogene (1998) vol. 17:3261-3270. |
Fanslow, William C., et al., “Structural Characteristics of CD40 Ligand That Determine Biological Function,” Immunology (1994) vol. 6:267-278. |
Gravestein, Loes A., et al., “Tumor Necrosis Factor Receptor Family Members in the Immune System,” Immunology (1998) vol. 10:423-434. |
Griffith, Thomas S., et al., “TRAIL: a Molecule with Multiple Receptors and Control Mechanisms,” Current Opinion in Immunology (1998) vol. 10:559-563. |
Gu, Wen-Zhen, et al., “Isolation, Purification, and Characterization of Immunosuppressive Compounds from Tripterygium:Triptolide and Tripdiolide,” Int. J. Immunopharmac. (1995) vol. 17(5):351-356. |
Pitti, Robert M., et al., “Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family,” The Journal of Biological Chemistry (1996) vol. 271(22):12687-12690. |
Shamon, Lisa A., et al., “Evaluation of the Mutagenic Cytotoxic, and Antitumor Potential of Tripolide, a Highly Oxygenated Diterpene Isolated from Tripterygium Wilfordii,” Cancer Letters (1997) vol. 112:113-117. |
Walczak, Henning, et al., “Tumoricial Activity of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand In Vivo,” Nature Medicine (Feb. 1999) vol. 5(2):157-163. |
Wiley, Steven R., et al., “Identification and Characterization of a New Member of the TNF Family that Induces Apoptosis,” Immunity (1995) vol. 3:673-682. |
Yang, Yili, et al., “Triptolide Induces Apoptotic Death of T Lymphocyte,” Immunopharmacology (1998) vol. 40:139-149. |